dbACP: A Comprehensive Database of Anti-Cancer Peptides

117 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07122 DEE GLLDLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 5.55 ± 0.35 µM
dbacp07123 DEE GLLDLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 6.05 ± 2.76 µM
dbacp07124 DEE GLLDLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 61.00 ± 1.41 µM
dbacp07125 EEE GLLELLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 6.25 ± 1.77 µM
dbacp07126 EEE GLLELLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 10.55 ± 3.46 µM
dbacp07127 EEE GLLELLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 78.75 ± 5.30 µM
dbacp07128 HEE GLLHLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 6.50 ± 0.71 µM
dbacp07129 HEE GLLHLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 4.95 ± 0.49 µM
dbacp07130 HEE GLLHLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 47.50 ± 11 µM
dbacp07131 KEE GLLKLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.75 ± 0.78 µM
dbacp07132 KEE GLLKLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.05 ± 0.21 µM
dbacp07133 KEE GLLKLLELLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 49.38 ± 13.26 µM
dbacp07134 DHE GLLDLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.75 ± 0.92 µM
dbacp07135 DHE GLLDLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.80 ± 0.14 µM
dbacp07136 DHE GLLDLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 17.25 ± 1.06 µM
dbacp07137 EHE GLLELLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.90 ± 0.28 µM
dbacp07138 EHE GLLELLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.55 ± 0.07 µM
dbacp07139 EHE GLLELLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 18.25 ± 1.06 µM
dbacp07140 HHE GLLHLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 16.70 ± 2.26 µM
dbacp07141 HHE GLLHLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 10.75 ± 0.78 µM
dbacp07142 HHE GLLHLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 53.25 ± 5.30 µM
dbacp07143 KHE GLLKLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.70 ± 0.14 µM
dbacp07144 KHE GLLKLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.92 ± 0.17 µM
dbacp07145 KHE GLLKLLHLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 53 ± 2.83 µM
dbacp07146 DKE GLLDLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.10 ± 0 µM
dbacp07147 DKE GLLDLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.57 ± 0.33 µM
dbacp07148 DKE GLLDLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 9.93 ± 0.25 µM
dbacp07149 EKE GLLELLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.80 ± 0.28 µM
dbacp07150 EKE GLLELLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.30 ± 0.14 µM
dbacp07151 EKE GLLELLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 8.00 ± 0.71 µM
dbacp07152 HKE GLLHLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.70 ± 0.28 µM
dbacp07153 HKE GLLHLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.90 ± 0.42 µM
dbacp07154 HKE GLLHLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 15.95 ± 0.78 µM
dbacp07155 KKE GLLKLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.05 ± 0.64 µM
dbacp07156 KKE GLLKLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.70 ± 0 µM
dbacp07157 KKE GLLKLLKLLLEAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 12.75 ± 1.20 µM
dbacp07158 DEH GLLDLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 5.35 ± 1.91 µM
dbacp07159 DEH GLLDLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 3.60 ± 0.42 µM
dbacp07160 DEH GLLDLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 36.48 ± 3.92 µM
dbacp07161 EEH GLLELLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.30 ± 0.14 µM
dbacp07162 EEH GLLELLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 3.60 ± 0.85 µM
dbacp07163 EEH GLLELLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 19.60 ± 3.96 µM
dbacp07164 HEH GLLHLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 28.60 ± 10.75 µM
dbacp07165 HEH GLLHLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 10.95 ± 1.06 µM
dbacp07166 HEH GLLHLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 106 ± 14 µM
dbacp07167 KEH GLLKLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.30 ± 0.42 µM
dbacp07168 KEH GLLKLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.35 ± 0.07 µM
dbacp07169 KEH GLLKLLELLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 49.25 ± 5.30 µM
dbacp07170 DHH GLLDLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 21.45 ± 2.47 µM
dbacp07171 DHH GLLDLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 11.90 ± 0.14 µM
dbacp07172 DHH GLLDLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 55.85 ± 18.88 µM
dbacp07173 EHH GLLELLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 25.35 ± 2.76 µM
dbacp07174 EHH GLLELLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 16.05 ± 3.18 µM
dbacp07175 EHH GLLELLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 117 ± 7 µM
dbacp07176 HHH GLLHLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 21.10 ± 6.93 µM
dbacp07177 HHH GLLHLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 9.50 ± 0.99 µM
dbacp07178 HHH GLLHLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 185 ± 7 µM
dbacp07179 KHH GLLKLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 5.20 ± 0.71 µM
dbacp07180 KHH GLLKLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 4.45 ± 0.49 µM
dbacp07181 KHH GLLKLLHLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 39.75 ± 5.30 µM
dbacp07182 DKH GLLDLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.45 ± 0.07 µM
dbacp07183 DKH GLLDLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.80 ± 0.28 µM
dbacp07184 DKH GLLDLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 21.13 ± 3.01 µM
dbacp07185 EKH GLLELLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.75 ± 0.07 µM
dbacp07186 EKH GLLELLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.18 ± 0.31 µM
dbacp07187 EKH GLLELLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 23.83 ± 0.81 µM
dbacp07188 HKH GLLHLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.45 ± 0.21 µM
dbacp07189 HKH GLLHLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 3.10 ± 0.57 µM
dbacp07190 HKH GLLHLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 18.88 ± 1.24 µM
dbacp07191 KKH GLLKLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.40 ± 0.85 µM
dbacp07192 KKH GLLKLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.20 ± 0.42 µM
dbacp07193 KKH GLLKLLKLLLHAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 13.30 ± 0.99 µM
dbacp07194 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.14 ± 0.52 µM
dbacp07195 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.70 ± 0.07 µM
dbacp07196 DEK GLLDLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 19.88 ± 2.65 µM
dbacp07197 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.10 ± 0.14 µM
dbacp07198 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.08 ± 0.18 µM
dbacp07199 EEK GLLELLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 32.88 ± 4.07 µM
dbacp07200 HEK GLLHLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.35 ± 1.06 µM
dbacp07201 HEK GLLHLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 3.45 ± 2.19 µM
dbacp07202 HEK GLLHLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 143.20 ± 80.33 µM
dbacp07203 KEK GLLKLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.60 ± 0.14 µM
dbacp07204 KEK GLLKLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.35 ± 0.07 µM
dbacp07205 KEK GLLKLLELLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 8.15 ± 0.49 µM
dbacp07206 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.75 ±0.49 µM
dbacp07207 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.02 ± 0.12 µM
dbacp07208 DHK GLLDLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 20.45 ± 2.05 µM
dbacp07209 EHK GLLELLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.35 ± 0.35 µM
dbacp07210 EHK GLLELLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.71 ± 0.13 µM
dbacp07211 EHK GLLELLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 25.00 ± 0 µM
dbacp07212 HHK GLLHLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.15 ± 0.07 µM
dbacp07213 HHK GLLHLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.75 ± 0.21 µM
dbacp07214 HHK GLLHLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 12.65 ± 1.91 µM
dbacp07215 KHK GLLKLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 2.59 ± 0.92 µM
dbacp07216 KHK GLLKLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.40 ± 0.14 µM
dbacp07217 KHK GLLKLLHLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 12.88 ± 1.24 µM
dbacp07218 DKK GLLDLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.95 ± 0.35 µM
dbacp07219 DKK GLLDLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.20 ± 0.14 µM
dbacp07220 DKK GLLDLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 10.40 ± 1.70 µM
dbacp07221 EKK GLLELLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.72 ± 0.21 µM
dbacp07222 EKK GLLELLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.19 ± 0.40 µM
dbacp07223 EKK GLLELLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 12.20 ± 1.84 µM
dbacp07224 HKK GLLHLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 3.40 ± 0.71 µM
dbacp07225 HKK GLLHLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 2.60 ± 0.42 µM
dbacp07226 HKK GLLHLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 12.23 ± 0.11 µM
dbacp07227 KKK GLLKLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 1.57 ± 0.24 µM
dbacp07228 KKK GLLKLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 1.35 ± 0.40 µM
dbacp07229 KKK GLLKLLKLLLKAAGW Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 9.65 ± 1.20 µM
dbacp07230 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.32 ± 0.07 µM
dbacp07231 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.23 ± 0.04 µM
dbacp07232 d-DHK GlldllhlllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 1.24 ± 0.03 µM
dbacp07233 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.44 ± 0.10 µM
dbacp07234 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.36 ± 0 µM
dbacp07235 d-DEK GlldllelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 5.84 ± 0.04 µM
dbacp07236 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER Breast Cancer IC50 = 0.29 ± 0.01 µM
dbacp07237 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay HMLER-shEcad Breast Cancer IC50 = 0.29 ± 0.01 µM
dbacp07238 d-EEK GllellelllkaaGw Synthetic Selective membrane perforation prevents resistance. MTT assay U-2 OS Bone Cancer IC50 = 4.78 ± 0.02 µM